A nonclassic CCAAT enhancer element binding protein binding site contributes to α-methylacyl-CoA racemace expression in prostate cancer

Molecular Cancer Research

Volumn 3, Issue 2, 2005, Pages 110-118

  Zha, Shan ^a   Isaacs, William B ^a,b,c  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; CCAAT ENHANCER BINDING PROTEIN; FATTY ACID; LUCIFERASE; MESSENGER RNA;

AMCR GENE; ARTICLE; BINDING SITE; BIOASSAY; CANCER CELL CULTURE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; ENHANCER REGION; ENZYME ACTIVITY; EPIGENETICS; FATTY ACID OXIDATION; GENE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REPORTER ASSAY; REPORTER GENE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

BINDING SITES; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEINS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; ENHANCER ELEMENTS (GENETICS); GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 13944249605     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-04-0178     Document Type: Article

References (30)

1. Ferdinandusse S, Denis S, Clayton PT, et al. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet 2000;24:188-91.
2. Jiang Z, Woda BA, Yang XJ. Alpha-methylacyl coenzyme A racemase as a marker for prostate cancer. JAMA 2002;287:3080-1.
3. Luo J, Zha S, Gage WR, et al. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002;62:2220-6.
4. Rubin MA, Zhou M, Dhanasekaran SM, et al. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 2002;287:1662-70.
5. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for the detection of prostate carcimona. Am J Surg Pathol 2001;25:1397-404.
6. Zha S, Ferdinandusse S, Denis S, et al. Alpha-methylacyl-CoA racemase as an androgen independent growth modifier in prostate cancer. Cancer Res 2003;63: 7365-76.
7. Mobley JA, Leav I, Zielie P, et al. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro. Cancer Epidemiol Biomarkers Prev 2003;12: 775-83.
8. Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002;419:624-9.
9. Lin X, Tascilar M, Lee WH, et al. GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am J Pathol 2001;159:1815-26.
10. Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 2004;279:31735-44.
11. De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 2004;24:4781-90.
12. Schacherer F, Choi C, Gotze U, Krull M, Pistor S, Wingender E. The TRANSPATH signal transduction database: a knowledge base on signal transduction networks. Bioinformatics 2001;17:1053-7.
13. Amery L, Fransen M, De Nys K, Mannaerts GP, Van Veldhoven PP. Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA racemase in humans. J Lipid Res 2000;41:1752-9.
14. Ferdinandusse S, Denis S, IJlst L, Dacremont G, Waterham HR, Wanders RJ. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 2000;41:1890-6.
15. Jiang MS, Lane MD. Sequential repression and activation of the CCAAT enhancer-binding protein-alpha (C/EBP alpha) during adipogenesis. Proc Natl Acad Sci U S A 2000;97:12519-23.
16. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ. CCAAT/ enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. Genes Dev 1996;10:804-15.
17. Wu FY, Tang QQ, Chen H, et al. Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-alpha. Proc Natl Acad Sci U S A 2002;99:10683-8.
18. Porse BT, Pedersen TA, Xu X, et al. E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo. Cell 2001;107:247-58.
19. Kaeferstein A, Krug U, Tiesmeier J, et al. The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML. Leukemia 2003;17:343-9.
20. Zahnow CA. CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Res 2002;4:113-21.
21. Milde-Langosch K, Loning T, Bamberger AM. Expression of the CCAAT/ enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins. Breast Cancer Res Treat 2003;79:175-85.
22. Cleutjens CB, van Eekelen CC, van Dekken H, et al. The human C/EBP delta (CRP3/CELF) gene: structure and chromosomal localization. Genomics 1993;16: 520-3.
23. Wu FY, Wang SE, Tang QQ, et al. Cell-cycle arrest by Kaposi's sarcoma-associated herpesvirus replication-associated protein is mediated at both the transcriptional and posttranslational levels by binding to CCAAT/enhancer-binding protein alpha and p21(CIP-1). J Virol 2003;77:8893-14.
24. Wu FY, Chen H, Wang SE, et al. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol 2003;77: 1481-500.
25. Zha S, Ferdinandusse S, Hicks JL, et al. Peroxisomal branched chain fatty acid β-oxidation pathway is upregulated in prostate cancer. Prostate. Epub 2004 Dec 14.
26. Zha S, Gage WR, Sauvageot J, et al. Cycooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Res 2001;61:8617-23.
27. Klein KA, Reiter RE, Redula J, et al. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997;3:402-8.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
29. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
30. Dyer BW, Ferrer FA, Klinedinst DK, Rodriguez R. A noncommercial dual luciferase enzyme assay system for reporter gene analysis. Anal Biochem 2000; 282:158-61.